Accessibility Menu
Guardian Pharmacy Services logo

Guardian Pharmacy Services(NYSE) GRDN

Market Cap$2.44BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2024)+141%
5 YearN/A
1 Year+63%
1 Month-3%
$38.27
-0.80%
-0.31Today
After hours$38.38+$0.11 (+0.29%)
Guardian Pharmacy Services last closing stock price
MetricPriceDate
Last closeUSD 38.462026-08-13
Guardian Pharmacy Services stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-2.56%USD 39.472026-08-06
1 month-3.05%USD 39.672026-07-14
3 month+5.05%USD 36.612026-05-15
Year to date+27.82%USD 30.092025-12-31
1 year+63.31%USD 23.552025-08-13
Since inception+141.13%USD 16.002024-09-26

Guardian Pharmacy Services Financials at a Glance

Market Cap

$2.44BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$1.46B

Net Income (TTM)

$65.91M

EPS (TTM)

$1.04

P/E Ratio

37.28

Dividend

$0.00

Beta (Volatility)

0.75 (Low)

Price

$38.27

Volume

310,918

Open

$39.08

Previous Close

$38.46

Daily Range

$37.71 - $39.51

52-Week Range

$23.14 - $47.02

Estimated Earnings Date

Aug 6, 2026

GRDN News

GRDN: Motley Fool Moneyball Superscore

74

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Guardian Pharmacy Services

Guardian helps seniors and patients get their medicine. The company delivers drugs to long-term care homes. It uses technology to track and package every pill.

Pills and Patient Care

  • Clinical Services: Personalized drug dispensing and clinical support for residents in long-term health care facilities (LTCFs).
  • Compliance Packaging: Medications organized by date and time into specialized dose formats to improve health outcomes.
  • Guardian Compass: Business dashboards that help local pharmacies plan and improve their daily business operations.
  • GuardianShield: Pharmacy and clinical programs for residents in assisted living facilities (ALFs) and behavioral health facilities (BHFs); these facility types account for over two-thirds of annual revenue.

Strategic Steps and Acquisitions

  • Acquired various pharmacy operations during 2025 for a total consideration of $16.9 million to expand its national footprint.
  • Increased the number of residents served to 207,000 as of March 2026, up from 189,000 a year earlier.
  • Completed a follow-on public offering of 1,020,000 shares of Class A common stock in March 2026.
  • Maintained a credit facility with Regions Bank to support working capital and future pharmacy expansions.

Why Local Service Matters

Guardian combines national scale with a local management model to provide high-touch service for facilities like assisted living homes. The company uses technology-enabled tracking to reduce administration errors and manage complex drug regimens for residents.

The Latest Financial Scorecard

  • Revenue reached $336.6 million in Q1 2026, up 2.2% year-over-year despite price cuts from the Inflation Reduction Act (IRA).
  • Net income rose to $13.3 million in Q1 2026, a 40.7% increase from the previous year.
  • Gross profit grew to $76.3 million in Q1 2026, up 18.6% compared to Q1 2025.
  • Free cash flow fell to $1 million in Q1 2026, down 91.1% from $11.7 million due to timing in working capital.

Bottom Line

Guardian has shifted from a private company to a public entity with a growing presence across 38 states. Its focus on the assisted living and behavioral health markets positions it within high-growth sectors of the pharmacy services industry.

AI Generated • May 25, 2026

Industry

Healthcare Providers and Services

Employees

3,600

CEO

Fred P. Burke

Headquarters

Atlanta, GA 30339, US

GRDN Financials

Key Financial Metrics (TTM)

Gross Margin

21.63%

Operating Margin

6.27%

Net Income Margin

4.50%

Return on Equity

30.80%

Return on Capital

36.61%

Return on Assets

14.86%

Earnings Yield

2.68%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.44BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

63.34M

Volume

310.92K

Avg. Volume

408.99K

Financials (TTM)

Gross Profit

$316.58M

Operating Income

$91.74M

EBITDA

$114.00M

Operating Cash Flow

$98.86M

Capital Expenditure

-$19.07M

Free Cash Flow

$79.78M

Cash & ST Invst.

$89.81M

Total Debt

$35.24M

Guardian Pharmacy Services Performance Analysis

Guardian Pharmacy Services annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 908,909,00014.8%
20232023-12-31USD 1,046,193,00015.1%
20242024-12-31USD 1,228,409,00017.4%
20252025-12-31USD 1,448,685,00017.9%
Guardian Pharmacy Services sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-309.6%
Q42025-12-315.3%
Q12026-03-31-15.3%
Q22026-06-304.5%
Guardian Pharmacy Services annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 0.57117.1%
20232023-12-31USD 0.38-32.5%
20242024-12-31USD -1.74N/A
20252025-12-31USD 0.78N/A
Guardian Pharmacy Services sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-307.1%
Q42025-12-31120.0%
Q12026-03-31-36.4%
Q22026-06-3061.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$351.77M

+2.2%

Gross Profit

$80.04M

+17.5%

Gross Margin

22.75%

N/A

Market Cap

$2.44BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$678.78K

N/A

Employees

3,600

N/A

Net Income

$21.87M

+142.2%

EBITDA

$29.95M

+64.1%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$89.81M

+377.3%

Total Debt

$35.24M

+4.6%

Accounts Receivable

$103.77M

+10.2%

Inventory

$50.44M

+14.2%

Long Term Debt

$27.86M

+5.1%

Short Term Debt

$7.38M

+2.7%

Return on Assets

14.86%

N/A

Return on Invested Capital

31.69%

N/A

Free Cash Flow

$25.41M

+62.6%

Operating Cash Flow

$30.03M

+50.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MDPediatrix Medical Group, Inc.
$26.37-0.49%
MESOMesoblast Limited
$16.49-1.73%
NUVBNuvation Bio Inc.
$6.10-4.98%
PRCTPROCEPT BioRobotics Corporation
$21.95+3.29%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$8.91-0.09%
SMCISuper Micro Computer
$39.16+0.04%
SPCXSpace Exploration Technologies
$141.29-0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.64+0.07%

Questions About GRDN

What is the current price of Guardian Pharmacy Services?

Guardian Pharmacy Services is trading at $38.46 per share.

What is the 52-week range for Guardian Pharmacy Services?

Over the past 52 weeks, Guardian Pharmacy Services has traded between $23.14 and $47.02.

How much debt does Guardian Pharmacy Services have?

As of the most recent reporting period, Guardian Pharmacy Services reported total debt of $35.24M.

How much cash does Guardian Pharmacy Services have on hand?

Guardian Pharmacy Services reported $89.81M in cash and cash equivalents in its most recent financial results.

What is Guardian Pharmacy Services’s dividend yield?

Guardian Pharmacy Services does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.